Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1361, 2011-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Iodine Supplementation: Benefits Outweigh Risks
By Delange F.
Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. :
Monovalent rotavirus vaccine benefits outweigh risks
Reactions Weekly, Vol. 1, Iss. 1357, 2011-01 ,pp. :
Large study confirms benefits of bisphosphonates outweigh risks
Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. :
Bevacizumab for NSCLC: benefits weighed against risks
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
Ipilimumab: will benefits outweigh risks in the eyes of the FDA?
Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. :